Erik Walldén
Président chez Erik Walldén AB
Profil
Erik Walldén is currently the Chairman & President of Wallden Associates at Mr. Walldén AB.
He is also the Chairman of Lumicks BV, Director at Affibody AB, Director at SymCel AB, Director at Beactica Therapeutics AB, and Director at Cellseed Sweden AB.
In the past, Mr. Walldén served as the President & Chief Executive Officer of Biacore International AB from 1989 to 2006.
He was also the President & Chief Executive Officer of Gyros AB from 2009 to 2013 and the Chief Executive Officer of Biotage AB.
Additionally, he held positions such as President & Chief Executive Officer of Affibody Medical AB, Chairman of Genovis AB, Deputy Chairman-Supervisory Board of Exiqon A, Chairman of AroCell AB, and Chairman of SwedenBIO Service AB.
He served as a Director at VisEn Medical, Inc. and Healthinvest Partners AB, as well as a Non-Executive Director at Tecan Group AG from 2011 to 2015.
He also served as a Director at Fastighets Ab Briggen, Proxeon Biosystems ApS, and Proxeon Bioinformatics A.
Mr. Walldén obtained his undergraduate degree from the University of Uppsala.
Postes actifs de Erik Walldén
| Sociétés | Poste | Début |
|---|---|---|
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | - |
| Erik Walldén AB | Président | 01/01/2006 |
Cellseed Sweden AB
 Cellseed Sweden AB Pharmaceuticals: OtherHealth Technology Part of CellSeed, Inc., Cellseed Sweden AB performs clinical trials. Setsuko Hashimoto has been the CEO of the Swedish company since 2015. | Directeur/Membre du Conseil | - |
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | 01/01/2017 |
SymCel AB
 SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Directeur/Membre du Conseil | 27/06/2018 |
Lumicks BV
 Lumicks BV Miscellaneous Commercial ServicesCommercial Services Lumicks BV is a Dutch life science tools company that develops equipment for dynamic single-molecule and cell avidity analysis. The company is based in Amsterdam, NL, and has subsidiaries in the Netherlands and the United States. The company's tools allow researchers to analyze complex biological processes in real-time by applying and measuring forces around biological interactions. Lumicks' C-Trap® optical tweezers and fluorescence & label-free microscopy, and Z-Movi® cell avidity analyzer are used to measure and select immune cells based on their real-time interactions with target cells. Lumicks was founded in 2014 by Olivier Heyning and Andrea Candelli, with Olivier Heyning serving as the CEO since then. | Président | - |
Anciens postes connus de Erik Walldén
| Sociétés | Poste | Fin |
|---|---|---|
| GENOVIS AB | Président | 05/05/2015 |
| TECAN GROUP AG | Directeur/Membre du Conseil | 16/04/2015 |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Directeur Général | - |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Erik Walldén
| University of Uppsala | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| GENOVIS AB | Health Technology |
| TECAN GROUP AG | Health Technology |
| BIOTAGE AB | Health Technology |
| AROCELL AB | Health Technology |
| Entreprise privées | 17 |
|---|---|
PerSeptive Biosystems, Inc.
 PerSeptive Biosystems, Inc. Medical SpecialtiesHealth Technology PerSeptive Biosystems developed and manufactured an integrated system for the purification, analysis, and synthesis of bio-molecules, reducing the time and cost of drug discoveries. BVP’s Chris Gabrieli invested in the company’s second round in December 1989. PerSeptive was purchased by Perkin Elmer, Inc. (NYSE: PKI) in 1998, it is a part of Applied Biosystems (NYSE: ABI), a subsidiary of Applera, Perkin Elmer’s former biotechnology division | Health Technology |
Biacore International AB
 Biacore International AB Pharmaceuticals: MajorHealth Technology Biacore International AB offers systems that generate data on the interactions between proteins and small molecule drug candidates. Its systems are used in pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture and life science research applications. The company serves research centers, pharmaceutical and biotechnology companies. Biacore International markets its products in the United States, Europe, Japan and Australia. The company was founded in 1984 and is headquartered in Uppsala, Sweden | Health Technology |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Health Technology |
VisEn Medical, Inc.
 VisEn Medical, Inc. Medical/Nursing ServicesHealth Services VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas. | Health Services |
Healthinvest Partners AB
 Healthinvest Partners AB Investment ManagersFinance Healthinvest Partners AB (Healthinvest) is an alternative investment management firm headquartered in Stockholm, Sweden. The firm was founded by Anders Hallberg and Carl Bennet in 2006. They are owned by Atle Investment Management AB, which is a subsidiary of Bure Equity AB (STO: BURE). Healthinvest manages HealthInvest Alpha Fund – which is an actively managed global healthcare fund with a value-based approach, and HealthInvest Sustainable Healthcare – a global healthcare fund where the investment philosophy is characterized by medical progress and innovation with a strong focus on sustainability. In addition, the firm manages the fund Avanza Healthcare on behalf of Avanza. | Finance |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
Fastighets Ab Briggen
 Fastighets Ab Briggen Real Estate DevelopmentFinance Part of Castellum AB, Fastighets Ab Briggen is a Swedish real estate company. The company is based in Oeresund, Sweden. Carl Ola Mattias Orsmark has been the CEO of the company since 2014. | Finance |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Proxeon Biosystems ApS
 Proxeon Biosystems ApS BiotechnologyHealth Technology Proxeon Biosystems ApS develops and sells technology, equipment, and supplies for biotechnology and clinical research. The company was founded by Ole Vorm on October 31, 2002 and is headquartered in Roskilde, Denmark. | Health Technology |
SymCel AB
SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Health Technology |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Proxeon Bioinformatics A/S | |
| Erik Walldén AB | |
Cellseed Sweden AB
Cellseed Sweden AB Pharmaceuticals: OtherHealth Technology Part of CellSeed, Inc., Cellseed Sweden AB performs clinical trials. Setsuko Hashimoto has been the CEO of the Swedish company since 2015. | Health Technology |
Lumicks BV
Lumicks BV Miscellaneous Commercial ServicesCommercial Services Lumicks BV is a Dutch life science tools company that develops equipment for dynamic single-molecule and cell avidity analysis. The company is based in Amsterdam, NL, and has subsidiaries in the Netherlands and the United States. The company's tools allow researchers to analyze complex biological processes in real-time by applying and measuring forces around biological interactions. Lumicks' C-Trap® optical tweezers and fluorescence & label-free microscopy, and Z-Movi® cell avidity analyzer are used to measure and select immune cells based on their real-time interactions with target cells. Lumicks was founded in 2014 by Olivier Heyning and Andrea Candelli, with Olivier Heyning serving as the CEO since then. | Commercial Services |
